ARCHIVES

FDA Approves Afinitor-Aromasin Regimen For Advanced HER2-Negative Breast Cancer

This article is from The Cancer Letter archive.

Vol. 35 No. 7 | July 27, 2012

Download PDF Visit The Full Archive

Related Articles

Afinitor Suspension Approved For Rare Pediatric Brain Tumor

August 31, 2012

Cancer Program Advocates Seek $170 Mil. Above President’s Budget, Vow To Close Bypass Gap

May 8, 1992

Biomedical Panel Says Cancer Panel Should Expand to Serve all NIH

June 4, 1976

NCI Support Crucial for Israel cancer Studies; Weizmann Top Recipient

June 17, 1977

Lenalidomide, An Altered Thalidomide, Shows Promise

November 24, 2006

Three Geneticists Of “Knockout” Mice Fame Win Lasker Award For Basic Research.

September 28, 2001